Routinely Updating Patients With Cancer About Variant of Uncertain Significance Reclassifications: A Premature Responsibility for Community Oncologists.

Autor: Battistuzzi L; Linda Battistuzzi, PhD, Medical Oncology Unit 2, IRCCS Ospedale Policlinico San Martino, Genoa, Italy, Department of Informatics, Bioengineering, Robotics and Systems Engineering, Università degli Studi di Genova, Genoa, Italy; Alberto Puccini, MD, Department of Biomedical Sciences, Humanitas University, Milan, Italy, Medical Oncology and Hematology Unit, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy; Stefania Sciallero, MD, Medical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino, Genoa, Italy; and Maurizio Genuardi, MD, Section of Genomic Medicine, Department of Life Sciences and Public Health, Università Cattolica del Sacro Cuore, Rome, Italy, Medical Genetics Unit, Department of Laboratory and Infectious Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy., Puccini A; Linda Battistuzzi, PhD, Medical Oncology Unit 2, IRCCS Ospedale Policlinico San Martino, Genoa, Italy, Department of Informatics, Bioengineering, Robotics and Systems Engineering, Università degli Studi di Genova, Genoa, Italy; Alberto Puccini, MD, Department of Biomedical Sciences, Humanitas University, Milan, Italy, Medical Oncology and Hematology Unit, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy; Stefania Sciallero, MD, Medical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino, Genoa, Italy; and Maurizio Genuardi, MD, Section of Genomic Medicine, Department of Life Sciences and Public Health, Università Cattolica del Sacro Cuore, Rome, Italy, Medical Genetics Unit, Department of Laboratory and Infectious Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy., Sciallero S; Linda Battistuzzi, PhD, Medical Oncology Unit 2, IRCCS Ospedale Policlinico San Martino, Genoa, Italy, Department of Informatics, Bioengineering, Robotics and Systems Engineering, Università degli Studi di Genova, Genoa, Italy; Alberto Puccini, MD, Department of Biomedical Sciences, Humanitas University, Milan, Italy, Medical Oncology and Hematology Unit, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy; Stefania Sciallero, MD, Medical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino, Genoa, Italy; and Maurizio Genuardi, MD, Section of Genomic Medicine, Department of Life Sciences and Public Health, Università Cattolica del Sacro Cuore, Rome, Italy, Medical Genetics Unit, Department of Laboratory and Infectious Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy., Genuardi M; Linda Battistuzzi, PhD, Medical Oncology Unit 2, IRCCS Ospedale Policlinico San Martino, Genoa, Italy, Department of Informatics, Bioengineering, Robotics and Systems Engineering, Università degli Studi di Genova, Genoa, Italy; Alberto Puccini, MD, Department of Biomedical Sciences, Humanitas University, Milan, Italy, Medical Oncology and Hematology Unit, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy; Stefania Sciallero, MD, Medical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino, Genoa, Italy; and Maurizio Genuardi, MD, Section of Genomic Medicine, Department of Life Sciences and Public Health, Università Cattolica del Sacro Cuore, Rome, Italy, Medical Genetics Unit, Department of Laboratory and Infectious Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
Jazyk: angličtina
Zdroj: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Sep 17, pp. JCO2401355. Date of Electronic Publication: 2024 Sep 17.
DOI: 10.1200/JCO-24-01355
Databáze: MEDLINE